Debating the future of medicines manufacturing in Glasgow’s Advanced Manufacturing Innovation District at PharmaTech Integrates 2023
Leaders from industry, academia, and governing bodies gathered in the heart of Glasgow’s Advanced Manufacturing Innovation District to discuss the future of medicines manufacturing at PharmaTech Integrates 2023. Life Science Integrates takes conferences to the coalface of innovative science, and PharmaTech Integrates took this to a new level, held across two state-of-the-art venues: the home of official event partner CPI’s Medicines Manufacturing Innovation Centre, and the newly opened National Manufacturing Institute Scotland.
Re-branded and Expanded, HealthTech Integrates 2023 is a hit with the MedTech, Digital Health, and HealthTech Community
In its 5th year running, Bio Integrates once again stood out as an event that not only showcases innovation in the biotech space, but provides the community with practical insights regarding funding, partnering, regulations and more by bringing together stakeholders from across the sector to share real life industry experience.
“This is an event for the sector to look at where we are, who we are, and how we’re going to get through the mess that the UK healthcare sector finds itself in,” began Martino. “But we’re a resilient community, and whatever gets thrown at us we tend to come back stronger.”
Report demonstrates Stevenage Bioscience Catalyst’s key role in delivering the economic benefit from leading edge UK life sciences
An independent report has been released today by Stevenage Bioscience Catalyst (SBC) that demonstrates its key role in delivering economic benefit from life sciences research and innovation in the UK.
Biotech start-ups successfully graduate from DATA accelerator programme at Stevenage Bioscience Catalyst
15 start-ups with huge potential have successfully completed the Data-driven Advanced Therapeutics Accelerator (DATA) programme at Stevenage Bioscience Catalyst (SBC), one of Europe’s most important science parks for life sciences.
An interview with Joe Healey
We interview Joe Healey, CEO and Co-Founder of NanoSyrinx, NanoSyrinx is a discovery-stage synthetic biology biotech developing a novel delivery modality for complex biologics.